Regeneron Pharmaceuticals | 10-K: FY2024 Annual Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results; Initiates Quarterly Dividend and Increases Total Share Repurchase Capacity to ~$4.5 Billion
Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-K: FY2023 Annual Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q3 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-K: FY2022 Annual Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q3 2022 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2022 Financial and Operating Results